AG
ABBV icon

ASO Group’s AbbVie ABBV Stock Holding History

ASO Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$494K Buy
+1,887
New +$484K 0.14% 57

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

ASO Group's ABBV Position: Q3 2026 in Review

ASO Group opened a new position in AbbVie (ABBV) in Q3 2026: 1,887 shares worth $494K. The stake represents 0.14% of the portfolio and ranks #57 among its holdings.

3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • ASO Group held 1,887 shares of AbbVie worth $494K as of Q3 2026.
  • AbbVie was a new ASO Group position in Q3 2026.
  • AbbVie made up 0.14% of ASO Group's portfolio in Q3 2026, its #57 holding.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on ASO Group's 13F filing for Q3 2026, filed 5 Nov 2026.